National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
Drug Information
    Posted: 02/05/2007    Updated: 08/14/2009
Related pages
Drug Information Summaries 1

Approval Process for New Cancer Treatments 2

Access to Investigational Drugs 3
Anastrozole

This page contains brief information about anastrozole and a collection of links to more information about the use of this drug, related research results, and ongoing clinical trials.

US Brand Name(s): Arimidex
FDA Approved: Yes

Anastrozole is approved by the Food and Drug Administration (FDA) to be used alone or together with other treatments for breast cancer in postmenopausal women.

Information from the NCI

Definition from the NCI Drug Dictionary 4 - Detailed scientific definition and other names for this drug.

Clinical Trial Results: Zoledronic Acid Improves Early Breast Cancer Treatment 5 - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Anastrozole, Tamoxifen, and Bone Loss on the ATAC (Arimidex, Tamoxifen Alone or in Combination) Trial 6 - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Anastrozole After Tamoxifen Better for Early Breast Cancer than Tamoxifen Alone 7 - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Anastrozole May Be Better than Tamoxifen at Shrinking Large Breast Tumors Before Surgery 8 - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Anastrozole Prevents Relapse in Early Breast Cancer - Results of the ATAC Trial 9 - Important clinical trial results for this drug, background information, and how the trial was done.

Targeted Cancer Therapies 10 - Information about the use of this drug to treat cancer.

Information from the National Library of Medicine (NLM)

MedlinePlus Information on Anastrozole 11 - A lay language summary of important information about this drug that may include the following:

  • warnings about this drug,
  • what this drug is used for and how it is used,
  • what you should tell your doctor before using this drug,
  • what you should know about this drug before using it,
  • other drugs that may interact with this drug, and
  • possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This NLM patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Clinical Trials

Clinical Trials for Anastrozole 12 - Check for trials from NCI's PDQ Cancer Clinical Trials Registry now accepting patients.

Important: The drug information on this Web page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.




Glossary Terms

breast cancer (brest KAN-ser)
Cancer that forms in tissues of the breast, usually the ducts (tubes that carry milk to the nipple) and lobules (glands that make milk). It occurs in both men and women, although male breast cancer is rare.
Food and Drug Administration
An agency in the U.S. federal government whose mission is to protect public health by making sure that food, cosmetics, and nutritional supplements are safe to use and truthfully labeled. The Food and Drug Administration also makes sure that drugs, medical devices, and equipment are safe and effective, and that blood for transfusions and transplant tissue are safe. Also called FDA.
postmenopausal (post-MEH-nuh-pawz-ul)
Having to do with the time after menopause. Menopause (“change of life”) is the time in a woman's life when menstrual periods stop permanently.


Table of Links

1http://www.cancer.gov/cancertopics/druginfo/alphalist
2http://www.cancer.gov/clinicaltrials/learning/approval-process-for-cancer-drugs
3http://www.cancer.gov/cancertopics/factsheet/Therapy/investigational-drug-access
4http://www.cancer.gov/Templates/drugdictionary.aspx?CdrID=42540
5http://www.cancer.gov/clinicaltrials/results/zoledronic-acid0608
6http://www.cancer.gov/clinicaltrials/results/ATAC-bone0308
7http://www.cancer.gov/clinicaltrials/results/anastrozole0805
8http://www.cancer.gov/clinicaltrials/results/neoadjuvant-anastrozole0805
9http://www.cancer.gov/clinicaltrials/results/ATAC1204
10http://www.cancer.gov/cancertopics/factsheet/Therapy/targeted
11http://www.nlm.nih.gov/medlineplus/druginfo/meds/a696018.html
12http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=42540&idtype=1